share

Dedesosaminyl-5-o-Mycaminosyl-10,11-Dihydromycinamicin Iv CAS NO 83883-27-6


Unit Price:

CAS No.:83883-27-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Dedesosaminyl-5-o-Mycaminosyl-10,11-Dihydromycinamicin Iv is a complex macrolide antibiotic derivative, representing a key intermediate or reference standard in advanced pharmaceutical research and development. This compound is critical for its role in the study and synthesis of novel antibacterial agents, particularly within the tylosin-related macrolide family. It is primarily utilized by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on developing next-generation antibiotics to combat resistant bacterial strains.

Application

  • Pharmaceutical Reference Standard: Serves as a high-purity analytical standard for quality control and method development in antibiotic manufacturing.
  • Antibacterial Research Intermediate: Used as a critical building block in the synthetic pathways for novel macrolide antibiotics.
  • Mechanistic Studies: Employed in biochemical and microbiological research to investigate the structure-activity relationships (SAR) of macrolide antibiotics.
  • Process Chemistry Development: Acts as a key intermediate in scaling up and optimizing the production of complex antibiotic active pharmaceutical ingredients (APIs).
  • Impurity Profiling: Utilized to identify and quantify related substances in bulk tylosin or similar macrolide antibiotic batches.

Basic Information

Product Name Dedesosaminyl-5-o-Mycaminosyl-10,11-Dihydromycinamicin Iv
CAS No. 83883-27-6
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms 10,11-Dihydrotylosin; 10,11-Dihydrotylosin aglycone; Dihydromycinamicin Iv; Tylosin related compound; 5-O-Mycaminosyltylactone derivative; Macrolide antibiotic intermediate; 10,11-Dihydro-5-O-mycaminosyltylonolide
EINECS Contact for details

Quality Control

Our Dedesosaminyl-5-o-Mycaminosyl-10,11-Dihydromycinamicin Iv is produced under strict quality management systems suitable for research and development applications. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided to ensure traceability and support your regulatory and research requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0%
Water Content (KF) ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.